Effect of COVID-19 on Thoracic Oncology Surgery in Spain: A Spanish Thoracic Surgery Society (SECT) Survey
Por:
Martinez-Hernandez, N, Silva, U, Sanchez, A, de la Cruz, J, Carillo, A, Sarceda, J, Lopez, S, Ramos, A, Diaz, J, Call, S, Counago, F, Trancho, F and Scientific Comm Spa
Publicada:
1 jun 2021
Resumen:
Simple Summary After the first wave of COVID-19, the Spanish Society of Thoracic Surgeons (SECT) surveyed its members to assess the impact of the pandemic on thoracic oncology surgery in one of the counties most affected by the virus. In May 2020, all SECT members were invited to complete a 40-item, multiple choice questionnaire by e-mail. The response rate was 19.0%. Surgical activity decreased by 95.7%, with 41.5% of centers performing surgery only in oncologic cases and 11.7% only in emergencies. More than half (56%) of multidisciplinary tumour board meetings (56%) were cancelled or conducted online. Standard protocols for early-stage disease were modified in 62.9% of centers. The results of this survey show that the COVID-19 pandemic severely limited thoracic oncology surgery activity. Here we describe and discuss the impact of the pandemic on thoracic surgery in Spain. After the first wave of COVID-19, the Spanish Society of Thoracic Surgeons (SECT) surveyed its members to assess the impact of the pandemic on thoracic oncology surgery in Spain. In May 2020, all SECT members were invited to complete an online, 40-item, multiple choice questionnaire. The questionnaire was developed by the SECT Scientific Committee and sent via email. The overall response rate was 19.2%. The respondents answered at least 91.5% of the items, with only one exception (a question about residents). Most respondents (89.3%) worked in public hospitals. The reported impact of the pandemic on routine clinical activity was considered extreme or severe by 75.5% of respondents (25.5% and 50%, respectively). Multidisciplinary tumour boards were held either with fewer members attending or through electronic platforms (44.6% and 35.9%, respectively). Surgical activity decreased by 95.7%, with 41.5% of centers performing surgery only on oncological patients and 11.7% only in emergencies. Nearly 60% of respondents reported modifying standard protocols for early-stage cancer and in the preoperative workup. Most centers (approximate to 80%) reported using full personal protective equipment when operating on COVID-19 positive patients. The COVID-19 pandemic severely affected thoracic oncology surgery in Spain. The lack of common protocols led to a variable care delivery to lung cancer patients.
Filiaciones:
:
Hosp Univ Ribera, Thorac Surg, Alzira 46600, Spain
Silva, U:
Hosp Univ Ramon & Cajal, Thorac Surg, Madrid 28034, Spain
Sanchez, A:
Hosp Univ Ramon & Cajal, Thorac Surg, Madrid 28034, Spain
de la Cruz, J:
Hosp Univ Puerta Hierro Majadahonda, Thorac Surg, Majadahonda 28222, Spain
Carillo, A:
Hosp Clin Univ Santiago, Thorac Surg, Santiago De Compostela 15706, Spain
Sarceda, J:
Hosp Clin San Carlos, Thorac Surg, Madrid 28040, Spain
Lopez, S:
Hosp Univ Ciudad Jaen, Thorac Surg, Jaen 23007, Spain
Ramos, A:
Hosp Clin Valladolid, Thorac Surg, Valladolid 47003, Spain
Diaz, J:
Hosp Univ Miguel Servet, Inst Inves Sanitaria Aragon, Thorac Surg, Zaragoza 50009, Spain
Call, S:
Hosp Univ Mutua Terrassa, Thorac Surg, Terrassa 08221, Spain
Counago, F:
Hosp Univ Quironsalud, Radiat Oncol, PL-28223 Pozuelo De Alarcon, Poland
Hosp La Luz, Radiat Oncol, Madrid 28003, Spain
Univ Europea Madrid, Radiat Oncol, Villaviciosa De Odon 28670, Spain
Trancho, F:
Hosp Clin San Carlos, Thorac Surg, Madrid 28040, Spain
Green Published, gold
|